Core Viewpoint - The article discusses a fraudulent scheme involving a prominent figure in the pharmaceutical industry, referred to as "Kris.Z" or 杨泽康, who exploited trust to mislead investors into participating in a stock that subsequently plummeted in value, resulting in significant financial losses for retail investors [1][24]. Group 1: Fraud Mechanism - The fraud was orchestrated by leveraging the trust built over years and the influencer's status in the pharmaceutical sector, promising high returns and low risks to lure investors into the scheme [8][30]. - Investors were misled with false assurances of market stability and potential gains, while the actual market conditions indicated an impending decline in the stock price of 翰思艾泰-B (03378) [30][39]. - The scheme involved a profit-sharing model where investors were promised a 55% return, creating an illusion of safety and profitability [30][39]. Group 2: Market Reaction and Consequences - During the initial trading phase, the stock only dropped by 10%, which was used to maintain investor confidence while insiders sold off their shares [11][33]. - Once the stock had fallen by 30%, the perpetrator claimed that there were no guarantees, leaving investors to fend for themselves [13][35]. - Post-event discussions revealed attempts to deflect responsibility, with claims that investors were solely responsible for their losses and that a safety net had existed but required further investment [15][37]. Group 3: Investor Impact - One investor reported a loss of 1.85 million, highlighting the severe financial impact of the scheme on individual investors [1][24]. - The article serves as a cautionary tale for retail investors, emphasizing the importance of due diligence and skepticism towards high-return promises from influential figures [1][24].
185 万血汗钱一夜蒸发!血泪控诉!HSAT国配惨遭“ 大 V” 收割